The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I ...
To earn CME related to this news article, click here. February 25, 2009 — A new joint guideline produced by the American Society of Clinical Oncology (ASCO) and the American Urological Association ...
Dr. Mary-Ellen Taplin joins the podcast to discuss the latest changes to the living guideline on metastatic castration-resistant prostate cancer (mCRPC). She reviews new treatment options for patients ...
Johnson & Johnson (NYSE:JNJ) reported multiple milestone clinical results at ASCO 2026 in autoimmunity, oncology, and myeloma. New data included the first FcRn-blocker efficacy signals in systemic ...
The MarketWatch News Department was not involved in the creation of this content. BALTIMORE, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Today, the American Urological Association (AUA), in partnership with the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results